<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0121-0793</journal-id>
<journal-title><![CDATA[Iatreia]]></journal-title>
<abbrev-journal-title><![CDATA[Iatreia]]></abbrev-journal-title>
<issn>0121-0793</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Antioquia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0121-07932016000300292</article-id>
<article-id pub-id-type="doi">10.17533/udea.iatreia.v29n3a04</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Características clínicas y presencia de prolactinoma en mujeres con hiperprolactinemia]]></article-title>
<article-title xml:lang="en"><![CDATA[Clinical characteristics and presence of prolactinoma in women with hyperprolactinemia]]></article-title>
<article-title xml:lang="pt"><![CDATA[Características clínicas e presencia de prolactinoma em mulheres com hiperprolactinemia]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López-Clavijo]]></surname>
<given-names><![CDATA[Carlos Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gaviria-Maya]]></surname>
<given-names><![CDATA[Juan Esteban]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Henao-Flórez]]></surname>
<given-names><![CDATA[Rodrigo Eduardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Piedrahíta-Gutiérrez]]></surname>
<given-names><![CDATA[Dany Leandro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Tecnológica de Pereira  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Caldas  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Caldas  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Fundación Universitaria Autónoma de las Américas  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>07</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>07</month>
<year>2016</year>
</pub-date>
<volume>29</volume>
<numero>3</numero>
<fpage>292</fpage>
<lpage>300</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0121-07932016000300292&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0121-07932016000300292&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0121-07932016000300292&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Objetivos:  caracterizar clínicamente a las pacientes que consultaron en InSer Pereira con diagnóstico de hiperprolactinemia, y determinar la prevalencia de prolactinomas.  Metodología:  descripción retrospectiva de 45 pacientes con diagnóstico de hiperprolactinemia y estudio por resonancia magnética (RM) contrastada de la silla turca entre enero del 2008 y julio del 2013. Se evaluaron las manifestaciones clínicas, la etiología, el nivel sérico de prolactina y los hallazgos imaginológicos.  Resultados:  las manifestaciones clínicas más frecuentes fueron: infertilidad, galactorrea y oligomenorrea. Hubo 26 casos de prolactinoma (57,8 %) y 12 de hiperprolactinemia idiopática (26,6 %). De los prolactinomas, 23 fueron microadenomas (tamaño promedio: 5,1 mm; DE ± 3,2 mm). El nivel sérico promedio de prolactina fue de 74,05 ng/mL (DE ± 13,33 ng/ mL). El 78 % de las pacientes con prolactinoma tenían la prolactina sérica por debajo de 70,0 ng/mL. No hubo asociación significativa entre el nivel sérico de prolactina y la presencia de prolactinoma.  Conclusión:  los prolactinomas son la principal causa de hiperprolactinemia y se encuentran en su mayor parte con elevaciones ligeras de la prolactina sérica. Se recomienda hacer RM contrastada de la silla turca en pacientes con hiperprolactinemia, independientemente del nivel de prolactina.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY  Objectives:  To clinically characterize women with hyperprolactinemia at InSer Pereira (Colombia) and to determine the prevalence of prolactinoma.  Methods:  Retrospective description of 45 patients with hyperprolactinemia, and contrasted pituitary magnetic resonance (MR), between January 2008 and July 2013. Clinical manifestations, etiology, serum prolactin level, and MR findings were included.  Results:  The most frequent clinical manifestations were: infertility, galactorrhea, oligomenorrhea. There were 26 cases of prolactinoma (57.8 %), and 12 of idiopathic hyperprolactinemia (26.6 %). Out of the 26 prolactinomas, 23 were microadenomas (average size 5.1 mm; SD ± 3.2 mm). Average serum prolactin level was 74.05 ng/mL (SD ± 13.33 ng/mL). 78 % of patients with prolactinoma had serum prolactin level under 70.0 ng/ mL. No significant association was found between serum prolactin level and the presence of prolactinoma.  Conclusion:  Prolactinomas are the main cause of hyperprolactinemia and they are found mostly with slight rise of serum prolactin. Pituitary MRI is recommended in patients with hyperprolactinemia, regardless of their prolactin level.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Objetivos:  caracterizar clinicamente às pacientes que consultaram em InSer Pereira com diagnóstico de hiperprolactinemia, e determinar a prevalência de prolactinomas.  Metodologia:  descrição retrospectiva de 45 pacientes com diagnóstico de hiperprolactinemia e estudo por ressonância magnética (RM) contrastada da sela túrcica entre janeiro de 2008 e julho de 2013. Se avaliaram as manifestações clínicas, a etiologia, o nível sérico de prolactina e as descobertas imagiológicos.  Resultados:  as manifestações clínicas mais frequentes foram: infertilidade, galactorreia e oligomenorreia. Houve 26 casos de prolactinoma (57,8 %) e 12 de hiperprolactinemia idiopática (26,6 %). Dos prolactinomas, 23 foram microadenomas (tamanho médio: 5,1 mm; DE ± 3,2 mm). O nível sérico médio de prolactina foi de 74,05 ng/mL (DE ± 13,33 ng/mL). 78 % das pacientes com prolactinoma tinham a prolactina sérica por debaixo de 70,0 ng/mL. Não houve associação significativa entre o nível sérico de prolactina e a presencia de prolactinoma.  Conclusão:  os prolactinomas são a principal causa de hiperprolactinemia e se encontram na sua maior parte com elevações ligeiras da prolactina sérica. Se recomenda fazer RM contrastada da sela túrcica em pacientes com hiperprolactinemia, independentemente do nível de prolactina.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Amenorrea]]></kwd>
<kwd lng="es"><![CDATA[Galactorrea]]></kwd>
<kwd lng="es"><![CDATA[Hiperprolactinemia]]></kwd>
<kwd lng="es"><![CDATA[Infertilidad]]></kwd>
<kwd lng="es"><![CDATA[Prolactina]]></kwd>
<kwd lng="es"><![CDATA[Prolactinoma]]></kwd>
<kwd lng="es"><![CDATA[Resonancia Magnética]]></kwd>
<kwd lng="en"><![CDATA[Amenorrhea]]></kwd>
<kwd lng="en"><![CDATA[Galactorrhea]]></kwd>
<kwd lng="en"><![CDATA[Hyperprolactinemia]]></kwd>
<kwd lng="en"><![CDATA[Infertility]]></kwd>
<kwd lng="en"><![CDATA[Magnetic Resonance Imaging]]></kwd>
<kwd lng="en"><![CDATA[Prolactin]]></kwd>
<kwd lng="en"><![CDATA[Prolactinoma]]></kwd>
<kwd lng="pt"><![CDATA[Amenorreia]]></kwd>
<kwd lng="pt"><![CDATA[Galactorreia]]></kwd>
<kwd lng="pt"><![CDATA[Hiperprolactinemia]]></kwd>
<kwd lng="pt"><![CDATA[Infertilidade]]></kwd>
<kwd lng="pt"><![CDATA[Prolactina]]></kwd>
<kwd lng="pt"><![CDATA[Prolactinoma]]></kwd>
<kwd lng="pt"><![CDATA[Ressonância Magnética]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Hyperprolactinaemia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prabhakar]]></surname>
<given-names><![CDATA[VKB]]></given-names>
</name>
</person-group>
<source><![CDATA[Best Pract Res Clin Obstet Gynaecol]]></source>
<year>2008</year>
<volume>22</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>341-53</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Hyperprolactinemia and prolactinomas]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mancini]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Casanueva]]></surname>
<given-names><![CDATA[FF]]></given-names>
</name>
<name>
<surname><![CDATA[Giustina]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Endocrinol Metab Clin North Am]]></source>
<year>2008</year>
<volume>37</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>67-99</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Hyperprolactinemia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chahal]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Schlechte]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Pituitary]]></source>
<year>2008</year>
<volume>11</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>141-6</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prolactin and breast cancer etiology: an epidemiologic perspective]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tworoger]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Hankinson]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
</person-group>
<source><![CDATA[J Mammary Gland Biol Neoplasia]]></source>
<year>2008</year>
<volume>13</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>41-53</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Guía clínica de diagnóstico y tratamiento del prolactinoma y la hiperprolactinemia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Halperin-Rabinovich]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Cámara-Gómez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[García-Mouriz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ollero-García-Agulló]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Endocrinol Nutr]]></source>
<year>2013</year>
<volume>60</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>308-19</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Treatment of hyperprolactinemia: a systematic review and meta-analysis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[ang]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
<name>
<surname><![CDATA[Mullan]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lane]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Hazem]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Prasad]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gathaiya]]></surname>
<given-names><![CDATA[NW]]></given-names>
</name>
</person-group>
<source><![CDATA[Syst Rev]]></source>
<year>2012</year>
<numero>1</numero>
<issue>1</issue>
<page-range>33</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Metabolic syndrome associated with hyperprolactinemia: a new indication for dopamine agonist treatment?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bernabeu]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Casanueva]]></surname>
<given-names><![CDATA[FF]]></given-names>
</name>
</person-group>
<source><![CDATA[Endocrine]]></source>
<year>2013</year>
<volume>44</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>273-4</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fritz]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Speroff]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neuroendocrinology]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Seigafuse]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Clinical Gynecologic Endocrinology and Infertility]]></source>
<year>2011</year>
<page-range>157-97</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Lippincott Williams & Wilkins]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Hyperprolactinemia: causes, diagnosis, and treatment]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Karasek]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pawlikowski]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lewi&#324;ski]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Endokrynol Pol]]></source>
<year>2006</year>
<volume>57</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>656-62</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Approach to the patient with persistent hyperprolactinemia and negative sellar imaging]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Glezer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bronstein]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
</person-group>
<source><![CDATA[J Clin Endocrinol Metab]]></source>
<year>2012</year>
<volume>97</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>2211-6</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Clinical practice. Prolactinomas]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klibanski]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[N Engl J Med]]></source>
<year>2010</year>
<volume>362</volume>
<numero>13</numero>
<issue>13</issue>
<page-range>1219-26</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The prolactinoma: Review]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Colao]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Res Clin Endocrinol Metab]]></source>
<year>2009</year>
<volume>23</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>575-96</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Pituitary adenomas: an overview]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lake]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Krook]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[SV]]></given-names>
</name>
</person-group>
<source><![CDATA[Am Fam Physician]]></source>
<year>2013</year>
<volume>88</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>319-27</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Clinical course and endocrinological characteristics of prolactinoma in children and adolescents]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[YM]]></given-names>
</name>
<name>
<surname><![CDATA[Choi]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Yoo]]></surname>
<given-names><![CDATA[HW]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Pediatr Endocrinol]]></source>
<year>2013</year>
<numero>1</numero>
<issue>1</issue>
<page-range>197</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Clinical and etiological profile of hyperprolactinemia-data from a tertiary care centre]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zargar]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[Laway]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Masoodi]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Bhat]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Wani]]></surname>
<given-names><![CDATA[AI]]></given-names>
</name>
<name>
<surname><![CDATA[Bashir]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
</person-group>
<source><![CDATA[J Assoc Physicians India]]></source>
<year>2005</year>
<numero>53</numero>
<issue>53</issue>
<page-range>288-90</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Pituitary imaging is indicated for the evaluation of hyperprolactinemia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bayrak]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Saadat]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Mor]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Chong]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Paulson]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sokol]]></surname>
<given-names><![CDATA[RZ]]></given-names>
</name>
</person-group>
<source><![CDATA[Fertil Steril]]></source>
<year>2005</year>
<volume>84</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>181-5</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vilar]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Freitas]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Naves]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Casulari]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Azevedo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Montenegro Jr]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[J Endocrinol Invest]]></source>
<year>2008</year>
<volume>31</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>436-44</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Etiological diagnosis of hyperprolactinemia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cortet-Rudelli]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Sapin]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bonneville]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Brue]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[Ann Endocrinol (Paris)]]></source>
<year>2007</year>
<volume>68</volume>
<numero>2-3</numero>
<issue>2-3</issue>
<page-range>98-105</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Frecuencia de adenoma hipofisiario en relación a la determinación de prolactina, Hospital Obrero Nº 1. Noviembre-Febrero de 2008, Bolivia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ormachea Salcedo]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez Enriquez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Callisaya Huahuamullo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Salcedo Ortiz]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[BIOFARBO]]></source>
<year>2008</year>
<numero>16</numero>
<issue>16</issue>
<page-range>616</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Molitch]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prolactin in Human Reproduction]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Strauss]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Barbieri]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Yen &amp; Jaffe's Reproductive Endocrinology]]></source>
<year>2009</year>
<edition>6ª</edition>
<page-range>57-78</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[W.B. Saunders]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prevalence of hyperprolactinemia and abnormal magnetic resonance imaging findings in a population with infertility]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Souter]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Baltagi]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Toth]]></surname>
<given-names><![CDATA[TL]]></given-names>
</name>
<name>
<surname><![CDATA[Petrozza]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<source><![CDATA[Fertil Steril]]></source>
<year>2010</year>
<volume>94</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1159-62</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Current treatment issues in female hyperprolactinaemia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Crosignani]]></surname>
<given-names><![CDATA[PG]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur J Obstet Gynecol Reprod Biol]]></source>
<year>2006</year>
<volume>125</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>152-64</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[How to investigate and treat: headache and hyperprolactinemia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bussone]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Usai]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Moschiano]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Curr Pain Headache Rep]]></source>
<year>2012</year>
<volume>16</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>365-70</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
